Bloomberg News

Galapagos Extends Service Collaboration With Chiesi Farmaceutici

October 12, 2011

Oct. 12 (Bloomberg) -- Galapagos NV’s BioFocus service division extended its collaboration with Chiesi Farmaceutici, a privately owned Italian pharmaceutical company, for a second time. This extension is valued at 2.8 million euros, Galapagos said in a statement.

Link to Statement:{NSN LSXTYO3PR6RN <GO>}

To contact the editor responsible for this story: Andrew Clapham at aclapham@bloomberg.net


Hollywood Goes YouTube
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus